Target intelligence / Profile preview

RNA, U1 small nuclear 103, pseudogene (RNU1-103P)

Target
RNU1-103P
Molecular classification
Pseudogene, Non-coding RNA (pseudogene), Small nuclear RNA (snRNA) pseudogene
01

Overview

RNU1-103P, or RNA, U1 small nuclear 103, pseudogene, is classified as a non-coding RNA pseudogene related to the U1 small nuclear RNA gene family[1][3]. U1 snRNA is an essential and highly conserved component of the spliceosome, the cellular machinery responsible for splicing pre-mRNAs in eukaryotic cells[3]. The genome contains numerous U1 snRNA pseudogenes, which are sequences similar to the authentic U1 snRNA loci but are traditionally annotated as nonfunctional due to mutations, deletions, or insertions that prevent their function as canonical snRNAs[3]. RNU1-103P itself has no known biological function, is not expressed as a functional RNA or protein, and is not considered a therapeutic target, receptor, enzyme, or marker in human disease or pharmacology[1][3]. Pseudogenes such as RNU1-103P are sometimes transcribed or even processed in certain contexts, but there is no evidence linking this particular pseudogene to any regulatory, disease, or drug-interactive function[1][3]. Thus, although it follows the naming convention for U1 snRNA pseudogenes, it does not fulfill the criteria of a bona fide drug or therapeutic target.

Other names
RNU1-103PRNA U1 small nuclear 103 pseudogene
02

Mechanism of action

Not applicable

03

Biological functions

None established for this pseudogene
04

Disease associations

None specific for this pseudogene
05

Safety considerations

None reported
06

Interacting drugs

None reported
07

Biomarkers

None reported

Beyond the preview

Go deeper on RNA, U1 small nuclear 103, pseudogene (RNU1-103P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 103, pseudogene (RNU1-103P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call